Cargando…
Artificial Intelligence Technologies for COVID-19 De Novo Drug Design
The recent covid crisis has provided important lessons for academia and industry regarding digital reorganization. Among the fascinating lessons from these times is the huge potential of data analytics and artificial intelligence. The crisis exponentially accelerated the adoption of analytics and ar...
Autores principales: | Floresta, Giuseppe, Zagni, Chiara, Gentile, Davide, Patamia, Vincenzo, Rescifina, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949797/ https://www.ncbi.nlm.nih.gov/pubmed/35328682 http://dx.doi.org/10.3390/ijms23063261 |
Ejemplares similares
-
Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion Process
por: Gentile, Davide, et al.
Publicado: (2022) -
Computer-Assisted Design of Peptide-Based Radiotracers
por: Patamia, Vincenzo, et al.
Publicado: (2023) -
1,2-Dibenzoylhydrazine as a Multi-Inhibitor Compound: A Morphological and Docking Study
por: Patamia, Vincenzo, et al.
Publicado: (2023) -
Steered Molecular Dynamics Simulations Study on FABP4 Inhibitors
por: Tomarchio, Rosario, et al.
Publicado: (2023) -
Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling Approach †
por: Floresta, Giuseppe, et al.
Publicado: (2019)